| Literature DB >> 30803967 |
Tatsuya Tada1, Tomomi Hishinuma1, Shin Watanabe2, Hiroki Uchida1, Mari Tohya1, Kyoko Kuwahara-Arai1, San Mya3, Khin Nyein Zan3, Teruo Kirikae4, Htay Htay Tin3.
Abstract
The emergence of multidrug-resistant (MDR) Pseudomonas aeruginosa has become a serious worldwide medical problem. This study was designed to clarify the genetic and epidemiological properties of MDR P. aeruginosa strains isolated from hospitals in Myanmar. Forty-five MDR P. aeruginosa isolates obtained from different patients in seven hospitals in Myanmar were screened using the broth microdilution method. The whole genomes of the MDR isolates were sequenced using a MiSeq platform (Illumina). Phylogenetic trees were constructed from single nucleotide polymorphism concatemers. Multilocus sequence types were deduced, and drug resistance genes were identified. Of the 45 isolates, 38 harbored genes encoding carbapenemases, including DIM-1, IMP-1, NDM-1, VIM-2, and VIM-5, and 9 isolates had genes encoding 16S rRNA methylases, including RmtB, RmtD3, RmtE, and RmtF2. Most MDR P. aeruginosa strains isolated in Myanmar belonged to sequence type 1047 (ST1047). This is the first molecular epidemiological analysis of MDR P. aeruginosa clinical isolates in Myanmar. These findings strongly suggest that P. aeruginosa ST1047 strains harboring carbapenemases, including DIM-, IMP-, NDM-, and VIM-type metallo-β-lactamases, have been spreading throughout medical settings in Myanmar.Entities:
Keywords: 16S rRNA methylases; Pseudomonas aeruginosazzm321990; aminoglycoside-modifying enzymes; carbapenemase; molecular epidemiology
Year: 2019 PMID: 30803967 PMCID: PMC6496111 DOI: 10.1128/AAC.02397-18
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191